Current Practice Patterns in the Management Of Alcohol Withdrawal Syndrome

Area of Science:

• Pharmacology
• Clinical Practice
• Healthcare Management

Background:

• Alcohol withdrawal syndrome (AWS) is a common clinical condition.
• Standard management often involves benzodiazepines (BZDs).
• Variations in AWS treatment protocols may exist across healthcare institutions.

Purpose of the Study:

• To investigate current practices in managing AWS in the Northeastern United States.
• To identify patterns in treatment selection for different severities of AWS.
• To assess the use of guidelines for benzodiazepine-refractory AWS.

Main Methods:

• A survey was distributed to pharmacy directors of hospitals in the Northeast.
• The survey focused on treatment options for alcohol withdrawal syndrome.
• Data from 90 hospitals were analyzed.

Main Results:

• Most hospitals use protocols for mild, moderate, and severe AWS.
• Two-thirds of hospitals lack protocols for benzodiazepine-refractory AWS.
• Benzodiazepine monotherapy is common for mild/moderate AWS, while combination therapy is used for severe/refractory cases.

Conclusions:

• Significant heterogeneity exists in AWS management, particularly for severe and refractory cases.
• Current guidelines may not adequately address the full spectrum of AWS treatment.
• There is a need for updated practice guidelines incorporating diverse treatment strategies.